Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, Natural product-based therapy for Hepatocellular carcinoma: Celastrol increases the expression of hepatocellular carcinoma, downregulated 1 (HEPN1) and inhibits the progression of hepatocellular carcinoma via down regulation of its target gene, 21/February/2015, 22.48, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Significance: This study suggests, for the first time, that Celastrol, by decreasing the expression of its target gene, it may increase the expression of HEPN1. Thereby, it may inhibit the progression of Hepatocellular carcinoma. Thus, pharmacological formulations encompassing “Celastrol or its analogues” can be used to treat Hepatocellular carcinoma.
Amount: $ 300
Undisclosed information: How Celastrol increases the expression of HEPN1
Web: http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
* Research cooperation
